title: Osteosarcoma following growth hormone therapy in recurrent acute lymphoblastic leukemia and Rapadilino syndrome.
authors.affiliation: Department of Pediatrics, New York Medical College and Maria Fareri Children's Hospital, Valhalla, New York, USA. claudio sandoval@nymc.edu
authors.forename: Claudio
authors.initials: C
authors.lastname: Sandoval
authors.forename: Julie
authors.initials: J
authors.lastname: Dunbar
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozkaynak
authors.forename: Somasundaram
authors.initials: S
authors.lastname: Jayabose
mesh_terms: D000293:Adolescent; D001003:Anal Canal / Q000002:abnormalities; D004392:Dwarfism / Q000150:complications* / Q000628:therapy; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000150:complications* / Q000628:therapy; D019382:Human Growth Hormone / Q000009:adverse effects*; D006801:Humans; D017880:Limb Deformities, Congenital / Q000150:complications* / Q000628:therapy; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D012516:Osteosarcoma / Q000139:chemically induced* / Q000209:etiology; D010329:Patella / Q000002:abnormalities; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000628:therapy; D011884:Radius / Q000002:abnormalities; D012008:Recurrence; D011038:Rothmund-Thomson Syndrome / Q000150:complications* / Q000628:therapy
chemical_list: D019382:Human Growth Hormone